Medical device company Penumbra (NYSE:PEN) will be reporting earnings this Tuesday after market hours. Here’s what you need to know.
Penumbra beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $324.1 million, up 16.3% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ constant currency revenue estimates and an impressive beat of analysts’ EPS estimates.
Is Penumbra a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Penumbra’s revenue to grow 9.4% year on year to $327.5 million, slowing from the 14.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.82 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Penumbra has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.4% on average.
Looking at Penumbra’s peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts’ expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%.
Read our full analysis of Boston Scientific’s results here and Intuitive Surgical’s results here.
Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Penumbra is down 9.2% during the same time and is heading into earnings with an average analyst price target of $311.94 (compared to the current share price of $233.10).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.